A year after receiving a booster dose of the R21/Matrix-M vaccine, 77% of children in Africa remained protected against mild and severe episodes of malaria.
A new malaria vaccine developed by Britain's University of Oxford is 80% effective in preventing infection, according to trial results published Thursday in The Lancet medical journal. Scientists say it represents a huge breakthrough that has the potential to save millions of lives and eventually eradicate the disease. The vaccine, named R21/Matrix-M, had already shown…
تكنولوجيا لقاح «أكسفورد» قد تحدث ثورة فـي مكافحة السرطان alwatan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alwatan.com Daily Mail and Mail on Sunday newspapers.